Design Therapeutics, Inc. 2026 Q1 - Results - Earnings Call Presentation
Design Therapeutics, Inc. released its Q1 2026 earnings call presentation on April 30, 2026, reporting an EPS of -$0.29, which beat estimates by $0.04, with zero revenue for the quarter. The company provided updates through a slide deck shared in conjunction with its earnings call. No further operational or financial details were disclosed in the summary.
Opening excerpt (first ~120 words) tap to expand
{"@context":"https://schema.org","@type":"NewsArticle","mainEntityOfPage":{"@type":"WebPage","@id":"https://seekingalpha.com/article/4897115-design-therapeutics-inc-2026-q1-results-earnings-call-presentation"},"author":{"@type":"Person","name":"SA Transcripts","url":"https://seekingalpha.com/author/sa-transcripts"},"publisher":{"@context":"http://schema.org","@type":"Organization","address":{"@type":"PostalAddress","streetAddress":"244 5th Ave","addressLocality":"New York","addressRegion":"NY","postalCode":"10001","addressCountry":"US"},"alternateName":["SeekingAlpha","SA"],"brand":[{"@type":"Brand","name":"Seeking Alpha Premium","url":"https://seekingalpha.com/subscriptions/premium"},{"@type":"Brand","name":"Seeking Alpha…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Seeking Alpha.
Discussion
0 commentsMore from Seeking Alpha
